TSPAN8 and melanoma: Furthermore, an anti-Tspan8 monoclonal antibody specifically targeting Tspan8+ melanoma xenografts in vivo significantly reduces dermal invasion by strongly impairing proMMP-9 activation process and collagen IV breakdown.